- All sections
- G - Physics
- G01N - Investigating or analysing materials by determining their chemical or physical properties
- G01N 33/88 - Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving prostaglandins
Patent holdings for IPC class G01N 33/88
Total number of patents in this class: 59
10-year publication summary
5
|
4
|
7
|
11
|
6
|
4
|
3
|
7
|
7
|
2
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
3 |
Korea University Research and Business Foundation | 2561 |
3 |
NB Health Laboratory Co., Ltd. | 24 |
3 |
F. Hoffmann-La Roche AG | 7958 |
2 |
Roche Diagnostics GmbH | 2745 |
2 |
Roche Diagnostics Operations, Inc. | 1375 |
2 |
Aventis Pharmaceuticals Inc. | 34 |
2 |
Fujirebio Inc. | 192 |
2 |
Laboratory Corporation of America Holdings | 655 |
2 |
Halliburton Energy Services, Inc. | 20165 |
1 |
The Board of Trustees of the Leland Stanford Junior University | 6054 |
1 |
University of South Florida | 1817 |
1 |
Ajou University Industry-academic Cooperation Foundation | 877 |
1 |
Analyte Works Ltd. | 1 |
1 |
Array BioPharma Inc. | 551 |
1 |
Avoscience, LLC | 11 |
1 |
Biocrates Life Sciences AG | 41 |
1 |
Biogen MA Inc. | 926 |
1 |
Biolipox AB | 48 |
1 |
Buck Institute for Research on Aging | 122 |
1 |
Other owners | 27 |